Journal of clinical gastroenterology
The Role of Endoscopic Bariatric Treatments in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.
Lillian Dawit, Cameron Quon, Vismaya Bachu, Hellen Jumo, Lavender Micalo, Danny Issa
Published: 202510.1097/MCG.0000000000002291
Abstract
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing global health concern, closely linked to obesity and metabolic syndrome, and characterized by hepatic steatosis, inflammation, and fibrosis. While lifestyle modifications a…
Preview only. Read the full abstract at the source